News about Global Pharma

Maiva Pharma Raises INR 1,000 Crore from Fundraising

Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).

Global Pharma | 03/05/2024 | By Aishwarya |  1091

Bound Tree Medical to Acquire QuadMed

Bound Tree Medical announced that the company has signed a definitive agreement to acquire QuadMed, Inc. Following a thoughtful integration period of 60-90 days, Bound Tree will seamlessly assume full operation of QuadMed's business, serving customers serving customers under the Bound Tree brand name.

Global Pharma | 02/05/2024 | By Manvi |  513

PainTEQ Gets Two New Patents for the LinQ Procedure, Advancing Treatments for SI Joint Dysfunction

These patents mark a notable step forward in medical device innovation, offering new hope to thousands suffering from debilitating lower back pain.

Global Pharma | 02/05/2024 | By Manvi |  879

Granules India Limited Gets ANDA Approval for Colchicine Capsules

Granules India Ltd. has declared that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, for Colchicine Capsules, 0.6 mg.

Global Pharma | 02/05/2024 | By Aishwarya |  836

United Imaging Receives FDA Clearance for uMR Jupiter 5T MRI System

The uMR Jupiter is hailed as the first ultra-high field system cleared for whole-body applications, setting a new standard in the field.

Global Pharma | 02/05/2024 | By Aishwarya |  1355

Medison Pharma and Alnylam Pharmaceuticals Expand Partnership to Reach More Patients Globally

Medison has developed a unique commercialization platform focused on delivering cutting-edge treatments for rare and severe diseases.

Global Pharma | 02/05/2024 | By Abha |  1458

INCOG Facility Receives FDA Approval for Commercial Drug Production

INCOG BioPharma Services has announced that its sterile injectable manufacturing facility has received approval from the US Food and Drug Administration (FDA) to produce a commercially approved drug product.

Global Pharma | 01/05/2024 | By Aishwarya |  664

AEYE Health Receives FDA Clearance for Autonomous AI Diagnosis of Diabetic Retinopathy

AEYE-DS is the sole solution enabling screenings with just one image per eye, boasting over 99 percent imageability.

Global Pharma | 01/05/2024 | By Abha |  990

Ingenium Therapeutics' Investigational NK Cell Therapy Granted Orphan Drug Designation for AML Treatment

This allogeneic NK cell therapy, derived from healthy donors, exhibits potent anti-cancer effects characterized by high purity and activity.

Global Pharma | 01/05/2024 | By Abha |  1073

Bayer and Evotec to Upgrade Precision Cardiology

Bayer and Evotec have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).

Global Pharma | 01/05/2024 | By Aishwarya |  618